NO990845L - Anvendelse av en kombinasjon av amoksicillin og klavulanat til fremstilling av et medikament for behandling av legemiddel-resistent Streptococcus-lungebetennelse - Google Patents

Anvendelse av en kombinasjon av amoksicillin og klavulanat til fremstilling av et medikament for behandling av legemiddel-resistent Streptococcus-lungebetennelse

Info

Publication number
NO990845L
NO990845L NO990845A NO990845A NO990845L NO 990845 L NO990845 L NO 990845L NO 990845 A NO990845 A NO 990845A NO 990845 A NO990845 A NO 990845A NO 990845 L NO990845 L NO 990845L
Authority
NO
Norway
Prior art keywords
drug
clavulanate
amoxicillin
manufacture
treatment
Prior art date
Application number
NO990845A
Other languages
English (en)
Other versions
NO990845D0 (no
Inventor
Richard Peregrine Bax
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO990845D0 publication Critical patent/NO990845D0/no
Publication of NO990845L publication Critical patent/NO990845L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO990845A 1996-08-24 1999-02-23 Anvendelse av en kombinasjon av amoksicillin og klavulanat til fremstilling av et medikament for behandling av legemiddel-resistent Streptococcus-lungebetennelse NO990845L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9617780.3A GB9617780D0 (en) 1996-08-24 1996-08-24 Method of treatment
PCT/GB1997/002235 WO1998007424A1 (en) 1996-08-24 1997-08-19 Use of a combination of amoxycillin and clavulanate in the manufacture of a medicament for the treatment drug-resistant streptococcus pneumonia

Publications (2)

Publication Number Publication Date
NO990845D0 NO990845D0 (no) 1999-02-23
NO990845L true NO990845L (no) 1999-04-19

Family

ID=10798919

Family Applications (1)

Application Number Title Priority Date Filing Date
NO990845A NO990845L (no) 1996-08-24 1999-02-23 Anvendelse av en kombinasjon av amoksicillin og klavulanat til fremstilling av et medikament for behandling av legemiddel-resistent Streptococcus-lungebetennelse

Country Status (20)

Country Link
US (2) US6214359B1 (no)
EP (1) EP0938312A1 (no)
JP (1) JP2000516243A (no)
KR (1) KR20000068329A (no)
CN (1) CN1233958A (no)
AR (1) AR008306A1 (no)
AU (1) AU722657B2 (no)
BR (1) BR9711642A (no)
CA (1) CA2264074A1 (no)
CO (1) CO5021201A1 (no)
CZ (1) CZ59299A3 (no)
GB (1) GB9617780D0 (no)
HU (1) HUP0201440A3 (no)
IL (1) IL128644A0 (no)
NO (1) NO990845L (no)
NZ (1) NZ334345A (no)
PL (1) PL331764A1 (no)
TR (1) TR199900413T2 (no)
WO (1) WO1998007424A1 (no)
ZA (1) ZA977564B (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030109503A1 (en) * 1995-06-06 2003-06-12 Smithkline Beecham P.L.C. Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
US6294199B1 (en) * 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US7250176B1 (en) * 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
WO2002030392A2 (en) 2000-10-12 2002-04-18 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
KR100456833B1 (ko) * 2002-08-01 2004-11-10 주식회사 대웅 아목시실린 및 클라불라네이트를 함유하는 유핵정
US8313776B2 (en) 2003-07-21 2012-11-20 Shionogi Inc. Antibiotic product, use and formulation thereof
AU2004258953B2 (en) * 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
EP1648418A4 (en) * 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
EP1653925A1 (en) * 2003-08-11 2006-05-10 Advancis Pharmaceutical Corporation Robust pellet
AU2004264356B2 (en) 2003-08-12 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
JP5686494B2 (ja) 2003-08-29 2015-03-18 シオノギ インコーポレイテッド 抗生物質製剤、その使用法及び作成方法
WO2005027877A1 (en) * 2003-09-15 2005-03-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
EP1701705A4 (en) * 2003-12-24 2007-08-08 Advancis Pharmaceutical Corp IMPROVED ABSORPTION OF MODIFIED RELEASE DOSAGE FORMS
JP2008505124A (ja) * 2004-07-02 2008-02-21 アドバンシス ファーマスーティカル コーポレイション パルス送達用錠剤
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) * 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
US9034410B2 (en) * 2011-08-22 2015-05-19 Thomas J. Vella Whole green coffee bean products and methods of production and use
WO2013173803A2 (en) * 2012-05-17 2013-11-21 Michael Spector Formulations of amoxicillin and clavulanate potassium and methods for using same
WO2013173808A2 (en) * 2012-05-17 2013-11-21 Michael Spector Methods for use of lower dose compositions of amoxicillin and clavulanate potassium and devices for use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
GB9408117D0 (en) 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
US5753434A (en) 1995-02-10 1998-05-19 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for altering sexual behavior
DZ2028A1 (fr) * 1995-05-03 2002-10-23 Smithkline Beecham Plc Médicaments destinés au traitement d'infections bactériennes en pédiatrie.
BR9610396A (pt) * 1995-09-07 1999-07-06 Smithkline Beecham Corp Formulação farmacêutica

Also Published As

Publication number Publication date
NZ334345A (en) 2000-10-27
NO990845D0 (no) 1999-02-23
AU4022697A (en) 1998-03-06
US6214359B1 (en) 2001-04-10
AU722657B2 (en) 2000-08-10
CN1233958A (zh) 1999-11-03
ZA977564B (en) 1999-02-22
EP0938312A1 (en) 1999-09-01
TR199900413T2 (xx) 1999-06-21
CO5021201A1 (es) 2001-03-27
JP2000516243A (ja) 2000-12-05
HUP0201440A2 (en) 2002-09-28
PL331764A1 (en) 1999-08-02
KR20000068329A (ko) 2000-11-25
GB9617780D0 (en) 1996-10-02
BR9711642A (pt) 2000-10-24
IL128644A0 (en) 2000-01-31
AR008306A1 (es) 1999-12-29
US20020114842A1 (en) 2002-08-22
CZ59299A3 (cs) 1999-08-11
WO1998007424A1 (en) 1998-02-26
HUP0201440A3 (en) 2003-04-28
CA2264074A1 (en) 1998-02-26

Similar Documents

Publication Publication Date Title
NO990845L (no) Anvendelse av en kombinasjon av amoksicillin og klavulanat til fremstilling av et medikament for behandling av legemiddel-resistent Streptococcus-lungebetennelse
DE69521799D1 (de) Polymer umhüllte tablette enthaltend amoxicillin und clavulanat
ATE243516T1 (de) Amoxicillin und clavulanat enthaltende arzneizubereitungen
NO180145C (no) Tannbörste og tildannelse av samme
NO304488B1 (no) 5-leddede heteroaryloksazolidinoner, anvendelse av disse for fremstilling av legemidler samt legemiddel inneholdende forbindelsen
NO180232C (no) Karboksylsyrederivater, legemidler inneholdende disse, og anvendelse av disse for fremstilling av legemidler
IS2048B (is) Notkun fumagillóls og afleiða þess við framleiðslu lyfja gegn þarmasýkingu
DE69415068D1 (de) Mikromotor und Herstellungsverfahren desselben
KR950703566A (ko) 티에노디아제핀 화합물 및 그의 의약 용도[thienodiazepine compound and medicinal use thereof]
HUP9901437A3 (en) Pharmaceutical formulation, containing amoxycillin and clavulanate
NO942720L (no) 1,5-benzobiazepinderivater og medisinsk anvendelse av disse
FI953479A0 (fi) 1-aryylipyrimidiinijohdannaiset ja niiden farmaseuttinen käyttö
NO20016198L (no) Orale farmasöytiske sammensetninger som inneholder taxaner og fremgangsmåter for anvendelse av samme i behandling
NO975037D0 (no) Preparat omfattende amoxycillin og clavulansyre
PT946175E (pt) Utilizacao de uma combinacao de inibidores de h+, k+ -atpase e de glucocorticiodes no tratamento de polipos nasais
NO922998D0 (no) Perforert drivkrutt, anordning for dets fremstilling og anvendelse av anordningen
NO933399D0 (no) Anordning og fremstilling av syntesegass, samt anvendelseav anordningen
DE59410107D1 (de) Chinoxaline und arzneimittel daraus
NO961046D0 (no) Fremgangsmåte for behandling av pasienter med akutt hjerteinfarkt som ikke gjennomgår trombolytisk behandling med hirudin og acetylsalicylsyre
AU2705495A (en) Use of rooperol and hypoxoside and their derivatives in the treatment of inflammatory
NO975522D0 (no) Oral administrasjon av pneumokokkale antigen
NO990948D0 (no) Anvendelse av PKC-inhibitorer til fremstilling av et medikament for behandling av HTLV-1-infeksjoner
DK0909167T3 (da) Lægemiddeltildeling-anordninger og fremgangsmåde til fremstilling
ID15808A (id) Penggunaan protease dibidang kedokteran
HUP0001584A3 (en) Pharmaceutical formulations comprising amoxocyllin and clavulanate

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application